Purpose: We evaluate the prognostic factors of recurrence, progression and
disease specific mortality in patients with primary superficial Ta and T1 t
ransitional cell carcinoma of the bladder.
Materials and Methods: We studied a cohort of 1,529 patients with primary s
uperficial transitional cell carcinoma of the bladder treated with transure
thral resection and random bladder biopsies. Mean followup was 4.2 years. S
tatistical analysis was performed using the Kaplan-Meier method and multiva
riate analysis was done with the Cox proportional hazards model with stepwi
se forward selection. All p values were 2-sided, with odds ratios and 95% c
onfidence intervals.
Results: Multiple tumors (odds ratio 2), tumor greater than 3 cm. (1.65) an
d carcinoma in situ (1.6) increased, whereas intravesical bacillus Calmette
-Guerin (BCG) instillations (0.39) decreased the risk of recurrence. Grade
3 disease (odds ratio 19.9), multiple tumors (1.9), tumor greater than 3 cm
. (1.7) and carcinoma in situ (2.1) increased, whereas BCG (0.3) decreased
the risk of progression. Grade 3 disease (odds ratio 14) and carcinoma in s
itu (odds ratio 3) increased the risk of disease specific mortality.
Conclusions: Neither tumor stage nor dysplasia influenced tumor evolution.
Multiple tumors, tumor greater than 3 cm. and intravesical BCG instillation
s were risk factors of recurrence and progression. Carcinoma in situ influe
nced recurrence, progression and disease specific mortality. Finally, the m
ain predictor of progression and mortality was grade 3 disease.